ALTEOGEN Inc. (KOSDAQ:196170)
South Korea flag South Korea · Delayed Price · Currency is KRW
433,500
+15,500 (3.71%)
Aug 29, 2025, 11:40 AM KST

ALTEOGEN Revenue

ALTEOGEN had revenue of 18.64B KRW in the quarter ending June 30, 2025, with 52.39% growth. This brings the company's revenue in the last twelve months to 158.06B, up 74.10% year-over-year. In the year 2024, ALTEOGEN had annual revenue of 102.85B with 6.56% growth.

Revenue (ttm)
158.06B
Revenue Growth
+74.10%
P/S Ratio
141.33
Revenue / Employee
1.02B
Employees
155
Market Cap
22.34T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024102.85B6.33B6.56%
Dec 31, 202396.52B67.72B235.08%
Dec 31, 202228.81B-9.94B-25.65%
Dec 31, 202138.75B-3.68B-8.67%
Dec 31, 202042.43B13.20B45.15%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics5,031.69B
Celltrion3,748.95B
Yuhan2,165.44B
SK Biopharmaceuticals620.28B
PharmaResearch392.31B
Peptron4.30B
LigaChem Biosciences146.42B
ABL Bio94.93B
Revenue Rankings